Tehran University of Medical Sciences

Science Communicator Platform

Share By
Exploring Atm and Methylation in Cancer: Emphasizing on Brain Tumors Publisher



Mehdipour P1 ; Karami F1
Authors

Source: Epigenetics Territory and Cancer Published:2015


Abstract

Ataxia-telangiectasia mutated (ATM) molecule governs one of the major cellular DNA repair pathway and is found to be crucial to inhibit cancer progression. Herein, after introducing the basic description about the ATM gene, its protein structure and functions, then we will discuss about the role of ATM gene aberrations in various types of cancers. It will be explained that some overlaps between Ataxia Telangiectasia (AT) patient and some other metabolic disorders relying on the importance of ATM gene mutations in the pathogenesis of AT disease. Finally, the spectrum of ATM promoter methyltion in different types of cancers will be provided. © Springer Science+Business Media Dordrecht 2015.
Related Docs
View other Related Docs
1. Ataxia Telangiectasia Syndrome: Moonlighting Atm, Expert Review of Clinical Immunology (2017)
2. Atm in Breast and Brain Tumors: A Comprehensive Review, Cancer Biology and Medicine (2018)
3. Ataxia-Telangiectasia: A Review of Clinical Features and Molecular Pathology, Pediatric Allergy and Immunology (2019)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Akrami (7)
Nima Rezaei (5)
Other Related Docs
4. Linking Atm Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in Atm Territory, Molecular Neurobiology (2015)
5. Ataxia-Telangiectasia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management, Expert Review of Clinical Immunology (2020)
6. The Association Between Atm Variants and Risk of Breast Cancer: A Systematic Review and Meta-Analysis, BMC Cancer (2021)
7. Genetic and Cellular Complexity of Brain Tumors, Cancer Genetics and Psychotherapy (2017)
8. Inflammation, a Significant Player of Ataxia–Telangiectasia Pathogenesis?, Inflammation Research (2018)
9. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients, Journal of Clinical Immunology (2022)
10. Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature, Frontiers in Immunology (2022)
11. The Prevalence of Ataxia Telangiectasia Mutated (Atm) Variants in Patients With Breast Cancer Patients: A Systematic Review and Meta-Analysis, Cancer Cell International (2021)
12. The Spectrum of Atm Gene Mutations in Iranian Patients With Ataxia-Telangiectasia, Pediatric Allergy and Immunology (2021)
13. Five- Hit Hypothesis in Atm Gene: An Individualized Model in a Breast Cancer Patient, Frontiers in Bioscience - Elite (2018)
14. Identification of Two Novel Mutations in the Atm Gene From Patients With Ataxia-Telangiectasia by Whole Exome Sequencing, Current Genomics (2019)
15. Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors, Cellular and Molecular Neurobiology (2018)
16. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)
17. Phospho-Smc1 In-Cell Elisa Based Detection of Ataxia Telangiectasia, International Journal of Pediatrics (2016)
18. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients, Immunological Investigations (2021)
19. Individual Radiosensitivity Assessment of the Families of Ataxia-Telangiectasia Patients by G2-Checkpoint Abrogation, Sultan Qaboos University Medical Journal (2018)
20. Molecular Contribution of Brca1 and Brca2 to Genome Instability in Breast Cancer Patients: Review of Radiosensitivity Assays, Biological Procedures Online (2020)